Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer’s Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years

BACKGROUND/OBJECTIVE: Structural brain magnetic resonance imaging (MRI) is not mandatory in Alzheimer’s disease (AD) research or clinical guidelines. We aimed to explore the use of structural brain MRI in AD/mild cognitive impairment (MCI) trials over the past 10 years and determine the frequency wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapoor, Arunima, Bartha, Robert, Black, Sandra E., Borrie, Michael, Freedman, Morris, Gao, Fuqiang, Herrmann, Nathan, Mandzia, Jennifer, Ozzoude, Miracle, Ramirez, Joel, Scott, Christopher J.M., Symons, Sean, Fischer, Corinne E., Frank, Andrew, Seitz, Dallas, Wolf, Michael Uri, Verhoeff, Nicolaas Paul L.G., Naglie, Gary, Reichman, William, Masellis, Mario, Mitchell, Sara B., Tang-Wai, David F., Tartaglia, Maria Carmela, Kumar, Sanjeev, Pollock, Bruce G., Rajji, Tarek K., Finger, Elizabeth, Pasternak, Stephen H., Swartz, Richard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242844/
https://www.ncbi.nlm.nih.gov/pubmed/32116253
http://dx.doi.org/10.3233/JAD-191097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242844/
https://www.ncbi.nlm.nih.gov/pubmed/32116253
http://dx.doi.org/10.3233/JAD-191097

Ejemplares similares